Proactive - Interviews for investors

Voyageur Pharmaceuticals CEO Brent Willis joined Steve Darling from Proactive to announce the commencement of human testing for the company's latest suite of barium contrast products, designed to optimize radiographic examinations of the gastrointestinal tract. The product lineup, including SmoothX, SmoothHD, SmoothLD, VisionHD, and VisionLD, is tailored to provide enhanced clarity, detail, and versatility for both adult and pediatric imaging applications.

Willis emphasized the importance of this milestone, as it represents a critical step toward the company's goal of entering the Canadian market in 2025. The human testing process is being conducted in two phase with Phase 1 in Q1 2025 and will focus on assessing product performance based on key indicators such as imaging quality, diagnostic yield, contrast administration success rates, detection sensitivity, and patient safety. The company says some additional metrics will include patient satisfaction, procedure completion rates, adverse event rates, and compliance rates will also be closely monitored.

These advanced formulations are designed to meet diverse clinical needs, ensuring high performance while maintaining safety and ease of use for patients. Voyageur aims to set a new standard in barium contrast agents, offering both precision and reliability in diagnostic imaging. This testing phase is an essential step in achieving regulatory approval and market readiness.

#proactiveinvestors #voyageurpharmaceuticalsltd #tsxv #vm #vyyrf #ctscan #xray #BrentWillis, #RainCage, #Nanoscience, #MRI, #CTScan, #MedicalBreakthrough, #Fullerenes, #Vanadium, #Gadolinium, #Bismuth, #Iodine, #Radiology, #MedicalInnovation, #DrugDevelopment, #Healthcare, #ScientificBreakthrough,

Hillcrest Energy Technologies CEO Don Currie joined Steve Darling from Proactive to share significant updates on the company’s strategic initiatives, marking a new phase in its evolution. These initiatives underscore the maturation of Hillcrest's proprietary Zero Voltage Switching (ZVS) technology and an expanded focus on application-specific development and accelerated commercialization.

Key to this transition is the appointment of Nad Karim as Vice President of Business Development. Karim brings over 20 years of experience in launching and scaling technology-driven businesses, with expertise in electric vehicle batteries, semiconductor IP, and advanced manufacturing technologies. His leadership is expected to drive Hillcrest’s efforts to bring its groundbreaking ZVS technology to market.

Currie highlighted the company's strategic shift from technology development to commercialization, including streamlining operations and designating specialized Centers of Excellence:

The Vancouver Lab will be dedicated to advancing power conversion technologies for grid applications, including renewable energy integration, energy storage, and data centers. The German Automotive Center of Excellence will focus on accelerating the adoption of ZVS technology in electric vehicles. The team has expanded its automotive offerings by incorporating FPGA-based control systems, complementing the existing microcontroller technology.

These strategic moves aim to enhance Hillcrest's capabilities in critical market segments, positioning the company to deliver scalable, industry-specific solutions. The streamlined approach and expanded expertise highlight Hillcrest’s readiness to drive commercialization and support the energy transition.

#proactiveinvestors #hillcrestenergytechnologiesltd #cse #heat #ptcqb #hlrtf

C3 Metals CEO Dan Symons joined Steve Darling from Proactive to unveil promising results from the company’s surface mapping and rock sampling program at its Khaleesi copper-gold project in Southern Peru. The project, located on the world-class Andahuaylas-Yauri Porphyry-Skarn belt, continues to deliver significant mineralization, showcasing the project's potential as an untapped resource.

Recent rock chip samples from the mapping and sampling program revealed grades of up to 1.80% copper, 4.4 g/t gold, and 403 ppm molybdenum, further expanding the previously identified skarn, porphyry, and epithermal vein copper-gold mineralization. Symons emphasized the strategic importance of the Khaleesi project, which covers a 30,000-hectare concession package and lies within 45 km of major copper operations such as the Las Bambas (MMG) and Constancia (Hudbay Minerals) mines.

In addition to sampling, the company has launched a comprehensive 50-metre grid soil sampling program across the project area. To deepen the understanding of Khaleesi’s subsurface potential, C3 Metals is undertaking multiple geophysical surveys, including a 45.5-line kilometre ground magnetic survey, a 24.5-line kilometre Induced Polarization (IP) survey, and a MT/AMT survey, all scheduled for completion by Q1 2025.

The data from these advanced exploration efforts will be instrumental in designing Khaleesi’s maiden drill program, a key milestone as the company seeks to unlock the full potential of this promising copper-gold deposit. With its strategic location on a world-class mineral belt and ongoing positive results, Khaleesi is positioned to become a major asset in C3 Metals' portfolio.

#proactiveinvestors #c3metalsinc #tsxv #cccm #otcqb #cuauf #CopperExploration #GoldMining #KhaleesiProject #PeruMining #ResourceInvesting #MiningUpdates

Eco Atlantic Oil & Gas Ltd chief executive Gil Holzman talked with Proactive's Stephen Gunnion about the company’s strategic moves and plans for 2025. Holzman explained a key development—the completion of a $12 million equivalent share buyback through a swap with Africa Oil, reducing the share count by 16%. He emphasised that this enhances shareholder value by increasing each shareholder’s stake in the company’s assets.

Holzman highlighted Eco Atlantic's portfolio of eight exploration licenses across Namibia, South Africa, and Guyana. He noted that the licenses include some of the hottest oil and gas exploration areas globally. Significant plans for 2025 include potential farm-out deals, drilling activities, and advancing partnerships with industry leaders such as TotalEnergies and QatarEnergy.

Additionally, Holzman announced the appointment of Emily Ferguson, a seasoned professional with 22 years of experience, to Eco Atlantic's board of directors. Ferguson’s extensive background in exploration and geoscience, including her work with TotalEnergies, is expected to be a valuable asset to the company.

Eco Atlantic is gearing up for an active year, with plans in motion across its global licenses. Holzman thanked Africa Oil for its collaboration and emphasised the impact of the reduced share count on the company’s future activities and shareholder returns.

Visit Proactive's YouTube channel for more videos, and don’t forget to give the video a like, subscribe to the channel, and enable notifications for updates!

#EcoAtlantic #OilAndGas #EnergyExploration #GilHolzman #AfricaOil #NamibiaExploration #SouthAfricaDrilling #GuyanaOil #EnergyInvesting #2025EnergyTrends

Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) CEO Ajan Reginald discussed the company’s proposed sale of subsidiary Lyramid to Pleiades Pharma with Proactive's Stephen Gunnion. Reginald explained that the sale, valued at a minimum of $10 million in cash and equity, marks the first step in Roquefort’s transformational strategy for 2025. He described it as a significant return on investment, as the company initially acquired Lyramid for £1 million in 2021.

Pleiades Pharma, led by Caroline Fortier, has a strong track record of successful exits, amounting to $750 million in the past decade. Reginald highlighted that the deal also validates Roquefort’s value creation model and underscores its current market undervaluation. The sale represents one and a half times Roquefort’s market capitalisation, showcasing the company’s ability to acquire, develop, and monetise high-value assets.

"We believe the upside potential with Pleiades Pharma is significant," Reginald stated, noting Pleiades' focus on building and exiting clinical asset portfolios. He also hinted at further opportunities, with two other assets in Roquefort’s portfolio already advancing toward value creation.

Stay tuned to Proactive’s channel for updates on this exciting deal, and don’t forget to give the video a like, subscribe, and enable notifications for future content.

#RoquefortTherapeutics #PharmaDeals #ClinicalAssets #LyramidSale #PleiadesPharma #BiotechInvestments #AssetSale #Biopharma #AjanReginald #ProactiveUpdates

Bitwise Asset Management European head Bradley Duke talked with Proactive about Bitcoin's record-breaking performance in 2024. Duke highlighted the cryptocurrency's 121% annual return, significantly outperforming traditional assets like the S&P 500 and gold. He also discussed Ethereum's strong year and the broader cryptocurrency market's 81% MSCI index rise.

Addressing Bitcoin's future, Duke explored both headwinds and tailwinds. A strong U.S. dollar, he explained, is currently a major challenge, contracting the global money supply and suppressing Bitcoin’s growth. However, Duke pointed to supply-side tailwinds like the 2024 halving and corporations adopting Bitcoin as a treasury asset, predicting these factors could help Bitcoin hit $200,000 by the end of 2025.

The conversation also touched on Bitwise's recent launch of a Solana staking ETP. Duke described how the product leverages smart tech for superior performance, reinvesting staking rewards to enhance returns.

For more insights into the cryptocurrency market and Bitwise's latest innovations, visit Proactive's YouTube channel. Don't forget to like the video, subscribe, and enable notifications for future updates.

#Bitcoin #Cryptocurrency #Bitwise #BradleyDuke #Bitcoin100K #Ethereum #CryptoInvesting #Solana #CryptoETP #ProactiveInvestors

Ilika PLC (AIM:IKA, OTCQX:ILIKF) CEO Graeme Purdy joined Proactive's Stephen Gunnion with news of the successful commissioning of manufacturing equipment for Stereax batteries at Cirtec Medical’s facility in Lowell, Massachusetts, in the US. He explained that the company has completed commissioning and is moving into process qualification, with commercial sales anticipated later this year.

Purdy discussed the partnership with Cirtec, emphasising its role as a tier-one manufacturing company catering to leading medical device OEMs. This collaboration involves a ten-year licensing agreement, with Ilika retaining responsibility for manufacturing proprietary cathodes in the UK before final assembly in the US.

Purdy also highlighted the unique features of Stereax batteries, designed for active implantable medical devices. Their miniaturisation and high energy density are enabling innovative applications in medical technology, reducing surgical interventions and improving patient recovery.

In addition to Stereax, Purdy provided updates on the company’s Goliath batteries for EVs and cordless appliances. The latest prototypes for these large-format batteries are expected midyear, with customer evaluations planned for late 2025.

Watch the full interview for more insights into Ilika PLC's plans for 2025, and hear directly from Graeme Purdy about the company’s progress and goals.

For more videos like this, visit Proactive’s YouTube channel. Don’t forget to like the video, subscribe to the channel, and turn on notifications for future updates.

#IlikaPLC #BatteryInnovation #StereaxBatteries #SolidStateTechnology #GoliathBatteries #MedicalDevices #EVBatteries #CleanEnergy #BatteryTechnology #ProactiveInterviews

Provaris Energy Ltd (ASX:PV1, OTC:GBBLF) managing director and CEO Martin Carolan talked with Proactive about the company's latest milestone: the culmination of a term sheet agreement. This achievement marks Provaris’ progress in compressed hydrogen shipping solutions, specifically within the European market.

Carolan explained the collaboration with Uniper and Norwegian Hydrogen, emphasising the tripartite agreement for hydrogen exports. The proposed project involves 42,500 tonnes of hydrogen annually over a minimum of ten years, a step that validates Provaris' commercial model. He noted, "It's the first true, visible, validation and accreditation of what we're doing because it's moved to public endorsement."

Provaris is advancing developments with compressed hydrogen carriers and looks to move from non-binding term sheets to binding agreements in the next six months. The company aims to play a significant role in the rapidly evolving European hydrogen market while continuing to develop export sites in Norway and explore opportunities in Finland.

Stay updated with more interviews and news from Proactive's YouTube channel. Like, subscribe, and turn on notifications for the latest insights into the hydrogen industry!

#ProvarisEnergy #HydrogenExport #CleanEnergy #CompressedHydrogen #RenewableEnergy #HydrogenEurope #EnergyInnovation #SustainableEnergy #MartinCarolan #ProactiveInterviews

hVIVO PLC (AIM:HVO) chief scientific officer Dr Andrew Catchpole talked with Proactive's Stephen Gunnion about the company’s recent success in developing a human challenge model for human metapneumovirus (hMPV). Catchpole highlighted the pilot characterisation study, which showed clear viral infection curves, strong symptom visibility, and ensured safety for volunteers.

He explained that hMPV, a significant respiratory pathogen affecting young children and the elderly, shares similarities with influenza and RSV. With this new challenge model, hVIVO now offers a powerful tool for fast-tracking the development of vaccines and antiviral therapies for hMPV. Catchpole said: “Human challenge trials are the fastest way to get efficacy data... you just can’t do this in field trials.”

Moreover, he discussed encouraging progress in hMPV vaccine research, building on RSV-related breakthroughs. The data from this study will also be presented at an upcoming RSV conference in Brazil, shedding light on immune responses and potential treatment paths.

Visit Proactive’s YouTube channel for more updates, and don’t forget to like the video, subscribe, and turn on notifications to stay informed.

#hVIVO #hMPV #HumanChallengeTrial #VaccineDevelopment #RespiratoryViruses #ClinicalResearch #ProactiveInvestors

Alasdair Bremner, CEO of Alusid, a Frontier IP Group PLC (AIM:FIPP) portfolio company, talked with Proactive's Stephen Gunnion about the company’s recent strides, starting with its first international distribution agreement with FRONT Materials. Based in Amsterdam, FRONT specialises in sustainable building materials and will distribute Alusid’s innovative wall and floor tiles. This deal includes exclusive rights in the Netherlands and non-exclusive rights across Europe and the US.

Bremner highlighted Alusid's commitment to sustainability, stating: “Our products are made predominantly from recycled materials, with around half the carbon footprint and water use of other products on the market.” The partnership will also include a new range of tiles, jointly developed and set for launch later this year.

In addition to pursuing more distribution agreements, Alusid is gearing up for an IPO in 2025. Bremner expressed optimism about the coming months, saying, “It’s going to be an exciting year ahead for us.”

Watch the full interview for more on Alusid’s plans for global growth and market impact.

For more exclusive interviews like this, visit Proactive's YouTube channel. Don’t forget to like, subscribe, and hit the notification bell for updates.

#SustainableTiles #RecycledMaterials #GreenBuilding #Alusid #FrontierIP #EnvironmentalInnovation #TileIndustry #EcoFriendlyDesign #IPO2025 #GlobalDistribution